Integrated rational design of cell factories for high value compounds
Industrial biotechnology is being increasingly considered as a means to lower the dependency on oil-derived raw-materials, increase the use of renewable resources and reduce the use of water, energy and the production of CO2 emiss...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BREEDER
Adaptative laboratory experiment at industrial scale
71K€
Cerrado
THE GREEN FACTORY
Avant garde R D platform and demonstration plant towards eff...
71K€
Cerrado
ADVANC1-METH
ADVANced engineering of C1 metabolism towards METHanol based...
188K€
Cerrado
ConCO2rde
Training network on the conversion of CO2 by smart autotroph...
3M€
Cerrado
BIO2017-88435-R
INGENIERIA METABOLICA EN ASHBYA GOSSYPII PARA EL DESARROLLO...
200K€
Cerrado
Información proyecto Magyc
Duración del proyecto: 18 meses
Fecha Inicio: 2017-02-28
Fecha Fin: 2018-09-14
Líder del proyecto
SILICOLIFE LDA
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
111K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Industrial biotechnology is being increasingly considered as a means to lower the dependency on oil-derived raw-materials, increase the use of renewable resources and reduce the use of water, energy and the production of CO2 emissions in the current chemical industry. However, although generally more sustainable and environmentally friendly, bioprocesses are normally not yet economically competitive. SILICO develops rational solutions for the optimization of microbes, targeted at the robust and cost-effective production of target compounds such as bio-fuels, food ingredients, chemical building blocks or biopolymers.
After more than six year working closely with leading chemical, materials, agriculture and synthetic biology companies as a development partner to maintain their market edge in increasingly competitive markets. The main current challenge of the company and central objective of this innovation action is to move from a purely service provider company into a product provider company, working in the integrated development of bio-processes, from the in silico design of cell factories to the in vivo implementation by the company itself or in a joint-venture/partnership model.
The company expects that, with the collaboration of the Innovation Associate, an innovation strategy exploiting the design of optimized microbes to overproduce selected high value chemicals with high market potential will be defined, thus generating its own IP to be licensed out or used in joint ventures with industrial partners.
As part of the Magyc project SILICO, with the collaboration of the Innovation Associate, aims at the development of a strategic plan to expand its operations into an integrated rational development company, exploiting the uniqueness features of its core technology and acquiring the required wet lab competences.